Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clostridium difficile bacteremia].

A Duthilly1, K Blanckaert, B Thielemans

  • 1Service de microbiologie, CH. Valenciennes.

Presse Medicale (Paris, France : 1983)
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consumption of alcohol-based hand rub in French nursing homes: results from a nationwide survey, 2018-2019.

The Journal of hospital infection·2021
Same author

Emergency ward ultrasound: clinical audit on disinfection practices during routine and sterile examinations.

Antimicrobial resistance and infection control·2021
Same author

Bacteremia caused by Elizabethkingia miricola in a patient with acute pancreatitis and peritoneal dialysis.

Medecine et maladies infectieuses·2020
Same author

In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France.

Medecine et maladies infectieuses·2018
Same author

[Bordetella trematum bacteremia in an immunosuppressed patient].

Medecine et maladies infectieuses·2018
Same author

Prospective evaluation of the management of urinary tract infections in 134 French nursing homes.

Medecine et maladies infectieuses·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Clostridium difficile can cause rare systemic infections, even outside the digestive tract. This case highlights that bacteremia is a possible, though uncommon, complication in immunocompromised patients.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Critical Care Medicine

Background:

  • Extra-digestive manifestations of Clostridium difficile infection are rare.
  • Clostridium difficile is a common cause of nosocomial diarrhea, often linked to antibiotic use.
  • Systemic infection is an exceptional but documented complication, particularly in intensive care settings.

Observation:

  • A 66-year-old immunocompromised patient with acute myeloblastic leukemia developed Clostridium difficile bacteremia.
  • The bacteremia was associated with an abscess of the anal margin.
  • The patient received metronidazole for treatment.

Findings:

  • Clostridium difficile bacteremia can occur in immunocompromised individuals.
  • Early identification and treatment of Clostridium difficile infection are crucial.

Related Experiment Videos

  • Favorable outcomes are possible with appropriate antimicrobial therapy.
  • Implications:

    • This case underscores the importance of considering Clostridium difficile in systemic infections among immunocompromised patients.
    • It highlights the potential for Clostridium difficile to cause severe, disseminated disease beyond the gastrointestinal tract.
    • Further research into the mechanisms and management of extra-digestive Clostridium difficile infections is warranted.